Pharmaceutical Technologies articles & resources on Made-in-China.com

Corning Exhibits Pharmaceutical Glass Technology at German Event

Oct 25, 2017

Corning is exhibiting its Valor Glass technology for pharmaceutical manufacturers at this year’s CPhI Worldwide event in Germany. The event is being held between 24 and 26 October in Frankfurt. Pharmaceutical firms Pfizer and ...

Tags: Pharmaceutical Glass

Forest Laboratories Has Entered Into a Definitive Agreement to Acquire Aptalis

Jan 9, 2014

Forest Laboratories, Inc. (NYSE:FRX) today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal (GI) and Cystic Fibrosis company, for $2.9 billion in cash from ...

Tags: Forest Laboratories, definitive agreement, acquisition, Aptalis

Johnson&Johnson Enters Collaborations with Two Canadian Drug Technology Developmen Centers

Dec 12, 2013

Johnson & Johnson Innovation and its affiliate Janssen have entered into new collaborations with two Canadian early-stage drug technology development centers, NEOMED and MaRS Innovation, to discover and develop new bio/pharmaceutical ...

Tags: Drug Technology Development, Medicine

European Commission Has Approved The Marketing Authorization of New Formulation

Dec 17, 2012

Aptalis Pharmaceutical Technologies announced that the European Commission has approved the marketing authorization of new oral granule formulation of Gilead Sciences' Viread, covering 27 countries of the European Union. Viread is ...

Tags: oral granule formulation, Pharmaceutical Technologies, Pharmaceutical

Aptalis Announced Co-Sponsorship of Controlled Release Society's Young Investigator Award

Nov 29, 2012

Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma, has announced its co-sponsorship of Controlled Release Society's Young Investigator Award and its participation in the thirty-ninth Annual Meeting & Exposition of the ...

Tags: Aptalis pharmaceutical, professor Berkland, colloids, polymers

An International Public-Private Partnership Was Bulit to Develop New Pediatric Formulation

Nov 27, 2012

TI Pharma, Merck KGaA, Astellas Pharma and the Swiss Tropical and Public Health Institute (Swiss TPH) have entered into an international public-private partnership (PPP) to develop new pediatric formulation of praziquantel for the treatment ...

Tags: Pediatric Formulation, Swiss TPH, treatment of schistosomiasis

The Two Patents, Owned by Aptalis and Licensed to Cephalon, Will Expire in 2023 and 2025

May 2, 2012

The US Court of Appeals for the Federal Circuit has ruled in favor of Aptalis Pharmatech and Cephalon, regarding the validity of two patents covering the Amrix muscle relaxant. The two patents, owned by Aptalis and licensed to ...

Tags: patent, appeal, medical product

Pharmaceutical Technologies